logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Dario Giugliano

department of advanced medical and surgical sciences

107H-index
668Paper Count
4.6WCitation Count
Published Papers 285
Publication Date
logo
Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies
errCardiovascular Diabetology
IF10.6
err2026-07-06
err0
errOAAI
errPaola Caruso; Nicole Di Martino; Miriam Longo; Lorenzo Scappaticcio; Giuseppe Bellastella; Maria Ida Maiorino; Katherine Esposito; Dario Giugliano
errShare
errSave
Glucagon-like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed?
errDiabetes, Obesity and Metabolism
IF0
err2025-11-03
err0
PREAI
errDario Giugliano MD; Paola Caruso PhD; Maria Ida Maiorino PhD; Giuseppe Bellastella MD; Katherine Esposito PhD
errShare
errSave
Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index
errDiabetes/Metabolism Research and Reviews
IF0
err2025-10-20
err0
PREAI
errSilvia Angelino; Antonietta Monda; Nicole Di Martino; Paola Caruso; Miriam Longo; Antonietta Maio; Mariluce Barrasso; Lorenzo Scappaticcio; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito; Maria Ida Maiorino
errShare
errSave
The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression
errEndocrine
IF2.9
err2025-09-15
err0
PREAI
errMaria Ida Maiorino; Nicole Di Martino; Silvia Angelino; Antonietta Maio; Paola Caruso; Michela Petrizzo; Lorenzo Scappaticcio; Miriam Longo; Daniela Forestiere; Chiara Porcellini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
errShare
errSave
BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor
errDiabetologia
IF10.2
err2025-08-28
err0
PREAI
errDario Giugliano; Miriam Longo; Paola Caruso; Lorenzo Scappaticcio; Alessandro Pontillo; Nicole Di Martino; Chiara Porcellini; Silvia Angelino; Mariangela Caputo; Giuseppe Bellastella; Maria Ida Maiorino; Katherine Esposito
errShare
errSave
Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts
errdiabetes obesity metabolism
IF0
err2025-07-07
err0
PREAI
errPaola Caruso PhD; Silvia Angelino MD; Rita Matrone MD; Lorenzo Scappaticcio PhD; Miriam Longo PhD; Alessandra Volatile MD; Michela Petrizzo PhD; Alessandro Pontillo MD; Mariangela Caputo PhD; Carla Carbone PhD; Maurizio Gicchino PhD; Giuseppe Bellastella PhD; Dario Giugliano MD; Katherine Esposito PhD; Maria Ida Maiorino PhD
errShare
errSave
Effect of SGLT-2 Inhibitors Versus DPP-4 Inhibitors on Peripheral Artery Disease Risk Among People With Type 2 Diabetes: A 48-Month Prospective Study
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-02-19
err0
PREAI
errGiugliano, Dario; Longo, Mirian; Caruso, Paola; Gicchino, Maurizio; Scappaticcio, Lorenzo; Bellastella, Giuseppe; Esposito, Katherine; Maiorino, Maria Ida
errShare
errSave
Semaglutide cuts kidney risk in obesity
errJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
IF3.5
err2024-11-04
err0
PREAI
errGiugliano, Dario; De Nicola, Luca; Maiorino, Maria Ida; Esposito, Katherine
errShare
errSave
Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-09-02
err1
PREAI
errGiugliano, Dario; Esposito, Katherine; De Nicola, Luca
errShare
errSave
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-01-17
err1
PREAI
errLongo, Miriam; Caruso, Paola; Scappaticcio, Lorenzo; Maiorino, Maria Ida; Bellastella, Giuseppe; Capuano, Annalisa; Esposito, Katherine; Giugliano, Dario
errShare
errSave
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
errENDOCRINE
IF2.9
err2023-10-03
err2
errOAAI
errGiugliano, Dario; Longo, Miriam; Scappaticcio, Lorenzo; Caruso, Paola; Gicchino, Maurizio; Petrizzo, Michela; Bellastella, Giuseppe; Maiorino, Maria Ida; Esposito, Katherine
errShare
errSave
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2022-03-16
err86
errOAAI
errGiugliano, Dario; Longo, Miriam; Signoriello, Simona; Maiorino, Maria Ida; Solerte, Bruno; Chiodini, Paolo; Esposito, Katherine
errShare
errSave
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-12-16
err70
errOAAI
errGiugliano, Dario; Longo, Miriam; Scappaticcio, Lorenzo; Bellastella, Giuseppe; Maiorino, Maria Ida; Esposito, Katherine
errShare
errSave
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-10-18
err46
errOAAI
errMaiorino, Maria Ida; Longo, Miriam; Scappaticcio, Lorenzo; Bellastella, Giuseppe; Chiodini, Paolo; Esposito, Katherine; Giugliano, Dario
errShare
errSave
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-10-12
err28
errOAAI
errGiugliano, Dario; Scappaticcio, Lorenzo; Longo, Miriam; Bellastella, Giuseppe; Esposito, Katherine
errShare
errSave
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-09-15
err147
errOAAI
errGiugliano, Dario; Scappaticcio, Lorenzo; Longo, Miriam; Caruso, Paola; Maiorino, Maria Ida; Bellastella, Giuseppe; Ceriello, Antonio; Chiodini, Paolo; Esposito, Katherine
errShare
errSave
Up and down waves of glycemic control and lower-extremity amputation in diabetes
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-07-06
err9
errOAAI
errCaruso, Paola; Scappaticcio, Lorenzo; Maiorino, Maria Ida; Esposito, Katherine; Giugliano, Dario
errShare
errSave
Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
errDIABETES CARE
IF16.6
err2021-04-21
err30
errOAAI
errGiugliano, Dario; Longo, Miriam; Caruso, Paola; Di Fraia, Rosa; Scappaticcio, Lorenzo; Gicchino, Maurizio; Petrizzo, Michela; Bellastella, Giuseppe; Maiorino, Maria Ida; Esposito, Katherine
errShare
errSave
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis
errDIABETES OBESITY & METABOLISM
IF5.7
err2021-03-30
err35
PREAI
errGiugliano, Dario; Longo, Miriam; Caruso, Paola; Maiorino, Maria Ida; Bellastella, Giuseppe; Esposito, Katherine
errShare
errSave
The residual cardiorenal risk in type 2 diabetes
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2021-02-05
err19
errOAAI
errGiugliano, Dario; Maiorino, Maria Ida; Bellastella, Giuseppe; Esposito, Katherine
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
C
Carlo La Vecchia
H-index: 188 · Papers: 3.0K
A
Antonia Trichopoulou
H-index: 143 · Papers: 1.1K
J
José M. Ordovás
H-index: 135 · Papers: 1.4K
J
Jordi Salas‐Salvadó
H-index: 128 · Papers: 1.1K
R
Ramón Estruch
H-index: 122 · Papers: 1.3K
View more